{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:55:33Z","timestamp":1771458933944,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejphar.2017.01.022","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T03:30:42Z","timestamp":1484710242000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Emodin, a compound with putative antidiabetic potential, deteriorates glucose tolerance in rodents"],"prefix":"10.1016","volume":"798","author":[{"given":"Sameer","family":"Abu Eid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor","family":"Torres-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina Theresa","family":"Hackl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mairam","family":"Kaplanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Luger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"F\u00fcrnsinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2017.01.022_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1242\/dmm.006239","article-title":"Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice","volume":"3","author":"Ayala","year":"2010","journal-title":"Dis. Models Mech."},{"key":"10.1016\/j.ejphar.2017.01.022_bib2","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.1021\/jf100046h","article-title":"The metabolic benefits of Polygonum hypoleucum Ohwi in HepG2 cells and Wistar rats under lipogenic stress","volume":"58","author":"Chao","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2017.01.022_bib3","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1002\/jcb.24232","article-title":"Promotion of adiponectin multimerization by emodin: a novel AMPK activator with PPARgamma-agonist activity","volume":"113","author":"Chen","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2017.01.022_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1476-5381.2010.00826.x","article-title":"Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice","volume":"161","author":"Feng","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.01.022_bib5","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1582-4934.2009.00701.x","article-title":"4-Aminoethylamino-emodin--a novel potent inhibitor of GSK-3beta--acts as an insulin-sensitizer avoiding downstream effects of activated beta-catenin","volume":"14","author":"Gebhardt","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ejphar.2017.01.022_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2015.11.045","article-title":"Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway","volume":"770","author":"Li","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.01.022_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2003.12.031","article-title":"Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus","volume":"92","author":"Li","year":"2004","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2017.01.022_bib8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1208\/s12248-010-9200-6","article-title":"Species and gender differences affect the metabolism of emodin via glucuronidation","volume":"12","author":"Liu","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ejphar.2017.01.022_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1479-5876-12-72","article-title":"Preparation of a nano emodin transfersome and study on its anti-obesity mechanism in adipose tissue of diet-induced obese rats","volume":"12","author":"Lu","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2017.01.022_bib10","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/jps.21978","article-title":"Differences in pharmacokinetics and ex vivo antioxidant activity following intravenous and oral administrations of emodin to rats","volume":"99","author":"Shia","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2017.01.022_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canlet.2013.08.023","article-title":"Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer","volume":"341","author":"Shrimali","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2017.01.022_bib12","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1074\/jbc.M112.441477","article-title":"Emodin regulates glucose utilization by activating AMP-activated protein kinase","volume":"288","author":"Song","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2017.01.022_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/med.20095","article-title":"Molecular mechanism of emodin action: transition from laxative ingredient to an antitumor agent","volume":"27","author":"Srinivas","year":"2007","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejphar.2017.01.022_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0031-9384(69)90126-7","article-title":"A method for frequent sampling of blood and continuous infusion of fluids in the rat without disturbing the animal","volume":"4","author":"Steffens","year":"1969","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2017.01.022_bib15","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/aps.2012.87","article-title":"Emodin, an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob\/ob mice","volume":"33","author":"Wang","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2017.01.022_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1463-1326.2010.01336.x","article-title":"Diabetes is an inflammatory disease: evidence from traditional Chinese medicines","volume":"13","author":"Xie","year":"2011","journal-title":"Diabetes, Obes. Metab."},{"key":"10.1016\/j.ejphar.2017.01.022_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.fitote.2009.08.020","article-title":"Anti-diabetic effects of emodin involved in the activation of PPARgamma on high-fat diet-fed and low dose of streptozotocin-induced diabetic mice","volume":"81","author":"Xue","year":"2010","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejphar.2017.01.022_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbrc.2006.11.134","article-title":"Emodin with PPARgamma ligand-binding activity promotes adipocyte differentiation and increases glucose uptake in 3T3-Ll cells","volume":"353","author":"Yang","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2017.01.022_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1440-1681.2008.05051.x","article-title":"Hypoglycaemic and hypolipidaemic effects of emodin and its effect on L-type calcium channels in dyslipidaemic-diabetic rats","volume":"36","author":"Zhao","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917300328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917300328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T05:53:42Z","timestamp":1530856422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299917300328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":19,"alternative-id":["S0014299917300328"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.01.022","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emodin, a compound with putative antidiabetic potential, deteriorates glucose tolerance in rodents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}